| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |